PMV Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects …

Biotechnology
US, Cranbury [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

PMV Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of PMVP's Analysis
CIK: 1699382 CUSIP: 69353Y103 ISIN: US69353Y1038 LEI: - UEI: -
Secondary Listings
PMVP has no secondary listings inside our databases.